Shree Ganesh Remedies Limited

BSE: SGRL540737ISIN INE414Y01015

Healthcare
Pharmaceuticals

Share price

₹648.85+23.90 (+3.82%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹759.00
52W low: ₹381.10
Off 52W high: -14.51%
1M return: -4.85%
3M return: +0.44%
6M return: +34.24%
1Y return: +30.67%
20D avg volume: 2,861
50 DMA: ₹656.94
200 DMA: ₹574.65

Key ratios Consolidated

Market cap: ₹832.79 Cr
Current price: ₹648.85
52W high / low: ₹759.00 / ₹381.10
Face value: ₹10.00
P/E: 68.79
P/B: 5.03
EPS (TTM): ₹9.43
Book value / share: ₹129.11
ROE: —
ROCE: 14.80%
Operating margin: —
Net margin: —
Debt / equity: 0.19
Net debt: ₹17.27 Cr
Interest cover: 7.75
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 157.4 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY22
Income statement
	23.29	14.36	33.20	21.11	30.32	24.67	24.43	27.05	32.33	24.78	37.33	21.13
	1.41	0.94	1.02	0.66	0.69	0.66	2.29	0.71	0.19	0.55	1.32	0.88
	24.70	15.30	34.22	21.76	31.00	25.33	26.72	27.76	32.52	25.32	38.66	22.01
	22.44	13.77	25.50	17.78	24.29	20.73	17.94	20.24	23.88	18.99	22.41	16.37
	13.80	8.40	11.03	8.95	12.20	8.74	9.51	10.23	8.79	8.84	12.16	9.06
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	0.01	—	0.00	—
	3.13	2.93	2.87	2.86	2.97	2.70	2.69	2.66	2.42	2.35	2.82	1.22
	0.58	0.32	0.88	0.74	1.01	0.94	0.97	0.39	0.44	0.32	0.16	0.03
	2.50	2.44	2.80	2.67	2.59	2.42	2.42	2.70	2.42	2.02	1.86	0.99
	6.72	5.99	4.72	5.18	5.14	5.95	6.02	—	5.37	5.91	4.52	3.32
	2.26	1.53	8.72	3.98	6.71	4.60	8.77	7.53	8.64	6.33	16.24	5.64
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	2.26	1.53	8.72	3.98	6.71	4.60	8.77	7.53	8.64	6.33	16.24	5.64
	0.63	0.41	2.46	0.89	1.76	1.15	2.18	2.10	2.23	1.68	3.66	1.43
	1.63	1.12	6.27	3.09	4.96	3.45	6.59	5.42	6.41	4.65	12.58	4.20
	1.27	0.87	4.88	2.41	3.86	2.68	5.13	4.22	4.97	3.62	10.00	3.50
Key metrics
	5.34	4.29	12.40	7.39	10.31	7.96	12.16	10.62	11.50	8.67	18.26	6.66
	22.90%	29.90%	37.30%	35.00%	34.00%	32.30%	49.80%	39.30%	35.60%	35.00%	48.90%	31.50%
	7.00%	7.80%	18.90%	14.60%	16.40%	14.00%	27.00%	20.00%	19.80%	18.80%	33.70%	19.90%
	1.50%	—	5.20%	—	4.20%	—	5.50%	—	—	—	—	—
	-23.20%	-41.80%	35.90%	-22.00%	-6.20%	-0.40%	-34.60%	—	—	—	—	—
	-67.10%	-67.50%	-4.90%	-43.00%	-22.60%	-25.80%	-47.60%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	91.96	109.29	108.60	125.89
	4.03	3.03	3.73	3.07
	95.98	112.32	112.33	128.96
	79.49	88.30	81.06	90.80
	42.18	40.92	37.38	61.05
	0.00	0.00	0.01	1.28
	11.79	11.40	10.12	8.41
	2.52	3.56	2.11	0.61
	10.41	10.47	9.57	6.11
	22.61	20.99	23.39	18.23
	16.49	24.02	31.27	38.16
	0.00	0.00	0.00	0.00
	16.49	24.02	31.27	38.16
	4.39	6.25	8.20	10.05
	12.11	17.76	23.07	28.11
	9.43	13.83	17.96	22.34
Key metrics
	29.42	38.05	42.95	44.88
	31.99%	34.80%	39.50%	35.70%
	13.17%	16.30%	21.20%	22.30%
	—	14.80%	19.00%	—
	-13.63%	0.60%	-13.70%	—
	-40.70%	-23.00%	-17.90%	—
	—	7.14	7.46	—
	—	1.34	1.33	—
	—	0.19	0.26	—
	—	17.27	28.29	—
	—	157.4	128.7	—
Balance sheet
	—	207.69	191.94	—
	—	85.86	77.58	—
	—	13.40	9.95	—
	—	32.56	22.27	—
	—	24.01	22.02	—
	—	3.18	4.09	—
	—	68.08	57.91	—
	—	9.44	5.97	—
	—	21.69	16.18	—
	—	30.67	38.24	—
	—	9.42	8.76	—
	—	21.25	29.48	—
	—	162.97	145.16	—
Cash flow
	—	23.74	30.66	—
	—	-9.89	-35.66	—
	—	-11.70	-1.09	—
	—	16.60	23.20	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	23.29	14.36	33.20	21.11	30.32	24.67	24.43	27.05	32.33	24.78	37.33	27.97
	1.41	0.94	1.02	0.66	0.69	0.66	2.29	0.71	0.19	0.55	1.32	1.11
	24.70	15.30	34.22	21.76	31.00	25.33	26.72	27.76	32.52	25.32	38.66	29.09
	22.44	13.77	25.50	17.78	24.29	20.73	17.94	20.23	23.87	18.99	22.40	21.66
	13.80	8.40	11.03	8.95	12.20	8.74	9.51	10.23	8.80	8.84	12.16	18.06
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	0.01	—	0.00	—
	3.13	2.93	2.87	2.86	2.97	2.70	2.69	2.66	2.41	2.35	2.82	1.99
	0.58	0.32	0.88	0.74	1.01	0.94	0.96	0.38	0.43	0.32	0.15	0.02
	2.50	2.44	2.80	2.67	2.59	2.42	2.42	2.70	2.42	2.02	1.86	1.88
	6.72	5.99	4.72	5.18	5.14	5.95	6.02	6.09	5.37	5.91	4.52	5.30
	2.26	1.53	8.72	3.98	6.71	4.60	8.78	7.54	8.65	6.33	16.25	7.42
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	2.26	1.53	8.72	3.98	6.71	4.60	8.78	7.54	8.65	6.33	16.25	7.42
	0.63	0.41	2.45	0.89	1.76	1.15	2.18	2.10	2.23	1.68	3.66	2.62
	1.63	1.12	6.27	3.10	4.96	3.45	6.60	5.43	6.42	4.65	12.59	4.80
	1.28	0.87	4.88	2.41	3.86	2.69	5.13	4.23	4.98	3.62	10.01	3.84
Key metrics
	5.34	4.29	12.40	7.39	10.31	7.96	12.16	10.62	11.50	8.67	18.26	9.32
	22.90%	29.90%	37.30%	35.00%	34.00%	32.30%	49.80%	39.30%	35.60%	35.00%	48.90%	33.30%
	7.00%	7.80%	18.90%	14.70%	16.40%	14.00%	27.00%	20.10%	19.90%	18.80%	33.70%	17.20%
	1.50%	—	5.20%	—	4.20%	—	5.50%	—	—	—	—	—
	-23.20%	-41.80%	35.90%	-22.00%	-6.20%	-0.40%	-34.60%	-3.30%	—	—	—	—
	-67.10%	-67.50%	-5.00%	-42.90%	-22.70%	-25.80%	-47.60%	13.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	91.96	109.29	108.60	125.89	90.22	71.29
	4.03	3.03	3.73	3.07	3.17	3.57
	95.98	112.32	112.33	128.96	93.38	74.86
	79.49	88.30	81.03	90.79	70.80	56.85
	42.18	40.92	37.38	61.05	47.83	37.42
	0.00	0.00	0.01	1.28	—	—
	11.79	11.40	10.12	8.41	5.87	4.73
	2.52	3.56	2.08	0.60	0.12	0.15
	10.41	10.47	9.57	6.11	3.72	3.34
	22.61	20.99	23.39	18.23	13.95	11.61
	16.49	24.02	31.30	38.17	22.58	18.00
	0.00	0.00	0.00	—	—	—
	16.49	24.02	31.30	38.17	22.58	18.00
	4.38	6.24	8.20	10.05	5.56	4.61
	12.12	17.77	23.10	28.12	17.02	13.40
	9.44	13.84	17.98	22.35	13.86	11.16
Key metrics
	29.42	38.05	42.95	44.88	26.42	21.49
	31.99%	34.80%	39.50%	35.70%	29.30%	30.10%
	13.18%	16.30%	21.30%	22.30%	18.90%	18.80%
	—	14.80%	19.00%	—	—	—
	-13.63%	0.60%	-13.70%	39.50%	26.60%	—
	-40.70%	-23.10%	-17.90%	65.20%	27.00%	—
	—	7.15	7.46	—	—	—
	—	1.34	1.33	—	—	—
	—	0.19	0.26	—	—	—
	—	17.31	28.34	—	—	—
	—	157.4	128.7	—	—	—
Balance sheet
	—	207.74	191.98	—	—	—
	—	85.83	77.53	—	—	—
	—	13.36	9.90	—	—	—
	—	32.56	22.27	—	—	—
	—	24.01	22.02	—	—	—
	—	3.18	4.09	—	—	—
	—	68.08	57.91	—	—	—
	—	9.44	5.97	—	—	—
	—	21.69	16.18	—	—	—
	—	30.67	38.24	—	—	—
	—	9.42	8.76	—	—	—
	—	21.25	29.48	—	—	—
	—	163.02	145.19	—	—	—
Cash flow
	—	23.75	30.66	—	—	—
	—	-9.89	-35.66	—	—	—
	—	-11.70	-1.06	—	—	—
	—	16.60	23.20	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +6.60%
Sales CAGR 5Y: —
Profit CAGR 3Y: +1.45%
Profit CAGR 5Y: —
Sales YoY (TTM): -13.63%
Profit YoY (TTM): -40.70%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -13.63%
Profit YoY (TTM): -40.70%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 72.83%

Quarter	September 2026	June 2026
Promoter %	72.83%	72.83%

Holder	Type	Holding	Previous	Change
CHANDULAL MANUBHAI KOTHIA	Promoter	48.76%	48.76%	0.00%
HANSHABEN CHANDUBHAI KOTHIA	Promoter	11.43%	11.43%	0.00%
POOJA GUNJAN KOTHIA	Promoter Group	4.79%	4.79%	0.00%
GUNJAN CHANDULAL KOTHIA	Promoter	3.21%	3.21%	0.00%
MANUBHAI JIVABHAI KOTHIYA	Promoter	1.84%	1.84%	0.00%
GUNJAN JAYANTIBHAI DHORAJIYA	Public	1.69%	1.70%	-0.01%
HETVI KETANKUMAR PATEL	Promoter Group	1.66%	1.66%	0.00%
V NAGA RAJA NAIDU	Public	1.27%	1.27%	0.00%
PARTH CHANDULAL KOTHIA	Promoter	1.06%	1.06%	0.00%
KOTHIA ASHOKKUMAR MANUBHAI (HUF)	Promoter Group	0.08%	0.08%	0.00%
VILASBEN ASHOKKUMAR KOTHIA	Promoter Group	0.00%	0.00%	0.00%
ASHOKKUMAR MANUBHAI KOTHIA	Promoter	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Shree Ganesh Remedies Limited	833	648.85	68.79	14.80%	-13.63% TTM	-40.70% TTM	+30.67%

Filings & corporate actions

Recent announcements

Investor Presentation1 Nov 2026 · Company Update / Investor Presentation
Press Release1 Nov 2026 · Company Update / Press Release / Media Release
Newspaper Publication1 Nov 2026 · Company Update / Newspaper Publication
Financial Results for quarter and half year ended September 30, 202631 Oct 2026 · Result / Financial Results
Outcome of Board Meeting31 Oct 2026 · Board Meeting / Outcome of Board Meeting
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve The Unaudited Financial ....27 Oct 2026 · Board Meeting / Board Meeting
Compliances - Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Appointment of Company Secretary and Compliance Officer3 Oct 2026 · Company Update / Appointment of Company Secretary / Compliance Officer
Resignation of Company Secretary / Compliance Officer3 Oct 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
Outcome of Board Meeting3 Oct 2026 · Others / Outcome without intimation
Intimation of Trading Window Closure26 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Voting Results12 Sep 2026 · AGM/EGM / AGM
Proceedings of Annual General Meeting of the Company12 Sep 2026 · AGM/EGM / AGM
Newspaper Publication for Notice of Annual General Meeting21 Aug 2026 · Company Update / Newspaper Publication
Annual Report FY 2025-2620 Aug 2026 · Others / Reg. 34 (1) Annual Report
Newspaper Publication13 Aug 2026 · Company Update / Newspaper Publication
Investor Presentation13 Aug 2026 · Company Update / Investor Presentation
Press Release13 Aug 2026 · Company Update / Press Release / Media Release
Appointment of Cost Auditors12 Aug 2026 · Company Update / General
Financial Results for the quarter ended on June 30, 202612 Aug 2026 · Result / Financial Results
Outcome of Board Meeting12 Aug 2026 · Board Meeting / Outcome of Board Meeting
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited (Standalone ....8 Aug 2026 · Board Meeting / Board Meeting
Appointment of Additional Director (Non executive, Independent)17 Jul 2026 · Company Update / Change in Directorate
Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 201813 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Clarification29 Jun 2026 · Company Update / General
Intimation of Closure of Trading Window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Schedule of Analyst /Institutional Investor Meetings25 Jun 2026 · Company Update / Analyst / Investor Meet
The Exchange has sought clarification from Shree Ganesh Remedies Ltd on June 25, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....25 Jun 2026 · Company Update / Clarification
Annual Secretarial Compliance Report for the year ended March 31, 202625 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Transcript of Earnings Call20 May 2026 · Company Update / Earnings Call Transcript
Audio Recording - Earnings Call held on May 15, 202616 May 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication15 May 2026 · Company Update / Newspaper Publication
Press Release15 May 2026 · Company Update / Press Release / Media Release
Investor Presentation14 May 2026 · Company Update / Investor Presentation
Outcome of Board Meeting14 May 2026 · Board Meeting / Outcome of Board Meeting
Financial Results14 May 2026 · Result / Financial Results
Intimation for invitation of Earnings Conference Call.12 May 2026 · Company Update / Analyst / Investor Meet
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve the Audited Standalone ....11 May 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 20188 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Voting Results6 Apr 2026 · AGM/EGM / EGM

Board meetings

31 Oct 2026 Board Meeting - Financial Results
12 Aug 2026 Board Meeting - Financial Results